EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE

Bibliographic Details
Main Authors:	Goodman, A, Gilbert, S, Colloca, S, Dicks, M, Hill, A, Draper, S
Format:	Conference item
Published:	2009

Similar Items

NEUTRALIZING ANTIBODY TITERS TO SIMIAN ADENOVIRAL VECTORS FOLLOWING ADCH63 ME-TRAP IMMUNIZATION IN HUMANS
by: Goodman, A, et al.
Published: (2009)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
by: Capone, S, et al.
Published: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
by: Capone, S, et al.
Published: (2010)

HETEROLOGOUS PRIME-BOOST VACCINATION WITH ADCH63 AND MVA EXPRESSING MSP1 CAN INDUCE PROTECTIVE EFFICACY AGAINST SPOROZOITE CHALLENGE IN VOLUNTEERS
by: Sheehy, S, et al.
Published: (2010)

New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1.
by: Goodman, A, et al.
Published: (2010)

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1, (vol 78, pg 4610, 2010)
by: Goodman, A, et al.
Published: (2011)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
by: Reyes-Sandoval, A, et al.
Published: (2005)

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
by: Sheehy, S, et al.
Published: (2011)

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors
by: Sheehy, S, et al.
Published: (2011)

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
by: Reyes-Sandoval, A, et al.
Published: (2008)

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
by: Reyes-Sandoval, A, et al.
Published: (2011)

In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector
by: Reka Lorincz, et al.
Published: (2023-02-01)

ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans
by: Sheehy, S, et al.
Published: (2012)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
by: O'Hara, G, et al.
Published: (2012)

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
by: Sheehy, S, et al.
Published: (2012)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
by: Dicks, M, et al.
Published: (2011)

Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016)

Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
by: Reyes-Sandoval, A, et al.
Published: (2010)

Erratum: Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
by: Reyes-Sandoval, A, et al.
Published: (2011)

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
by: Elias, S, et al.
Published: (2014)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Ewer (nee Russell), K, et al.
Published: (2017)

Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1.
by: Douglas, A, et al.
Published: (2010)

Prime-boost vectored malaria vaccines: progress and prospects.
by: Hill, A, et al.
Published: (2010)

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
by: Fitzgerald, J, et al.
Published: (2003)

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses, (vol 78, pg 152, 2010)
by: Reyes-Sandoval, A, et al.
Published: (2011)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
by: von Delft, A, et al.
Published: (2017)

Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
by: Folegatti, PM, et al.
Published: (2019)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
by: Antrobus, R, et al.
Published: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
by: Antrobus, R, et al.
Published: (2014)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
by: Katie Ewer, et al.
Published: (2017-12-01)

Blood-Stage Malaria Vaccines : MSP1 19
by: Chakrit Hirunpetcharat
Published: (2015-02-01)

Simian malaria in Brazil
by: Leonidas M. Deane
Published: (1992-01-01)

Adenoviral vectors as novel vaccines for influenza.
by: Coughlan, L, et al.
Published: (2015)

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.
by: Sheehy, S, et al.
Published: (2012)

Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
by: Rolling Judith A, et al.
Published: (2010-02-01)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
by: Alessandra Vitelli, et al.
Published: (2017-12-01)

Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.
by: Forbes, E, et al.
Published: (2011)

Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.
by: Sridhar, S, et al.
Published: (2008)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
by: Meirong Wang, et al.
Published: (2021-03-01)